Welcome to Equity.Guru’s Roundtable where our writers weigh in on the pros and cons of a spotlight company, break out where they see value, and help you avoid public markets pitfalls.

Today, our focus is on Filament Health (FH.NEO), who is breaking new ground with the natural extraction of psychedelics rather than rushing to a lab like the competition. After all, if Mother Nature got it right the first time, why do we need to re-invent the wheel?

Enjoy!